Dr. Vahan Kassabian

Dr. Vahan Kassabian
We are pleased to announce that Dr. Vahan Kassabian has joined Advanced Urology as the Director of the Atlanta Prostate Center and Advanced Therapeutics. This prostate center of excellence empowers patients from across the country to receive the latest, most innovative treatments combined with compassionate, personalized care. He specializes in complex oncological cases while providing novel therapies for patients with advanced cancer. He is a nationally recognized surgeon and pioneer in HIFU (High Intensity Focused Ultrasound), a truly minimally invasive procedure for localized prostate cancer. He is also considered a key opinion leader by industry for treatments in prostate cancer as an advisor and consultant. Dr. Kassabian earned his medical degree from University of Montreal, Quebec, then went on to complete his urologic residency at the University of Montreal. He completed further training as a research fellow in urologic oncology at Baylor College of Medicine in Houston, Texas. There he served as clinical instructor of urologic oncology before transitioning to assistant professor of surgery at Emory University. It was at Emory that Dr. Kassabian was awarded “Teacher of the Year” for his role in the advancement of education. He also served as Chief of Urology at the VA Hospital in Atlanta. Some of Dr. Kassabian’s former notable appointments include Medical Director of Georgia Urology, P.A., and member of the Cancer Committee, Peer Review Committee, and Contractor Advisory Committee of CAHABA. He currently serves as the Urology Consultant for Palmetto, the regional Medicare carrier, Contributing Editor for the publication “Reviews in Urology” and is a reviewer for “Urology Practice.” Voted one of Atlanta Magazine’s Top Doctors in 2018, he has extensive experience in clinical research, numerous national and international presentations, publications and book chapters, mostly related to cancer and prostate disease. Dr. Kassabian holds memberships in the American Urologic Association, the Canadian Urological Association, LUGPA, and the Society of Urologic Oncology. You can find Dr. Kassabian practicing at multiple Advanced Urology locations starting in early 2019.

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only